This is a very important and complex question.
We do have a pandemic influenza vaccine strategy in Canada that involves readiness contracts so that we can secure both through a domestic supplier, which would be a primary supplier, as well as an offshore supplier in the case of a pandemic influenza.
In this case, for vaccines, we felt that it was important to have some modest supply, given the very high uncertainty of a spillover from the U.S. to Canada, as well as the need to protect human health.